Clinical Trial Update: PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates pegylated liposomal doxorubicin (PLD) with ifosfamide as first-line treatment for advanced or metastatic soft tissue sarco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: Fudan University | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN